Literature DB >> 14997295

EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units.

C Brun-Buisson1, P Meshaka, P Pinton, B Vallet.   

Abstract

OBJECTIVE: Ten years ago 8.4% of patients in French intensive care units (ICUs) were found to have severe sepsis or shock and 56% died in the hospital. As novel therapies for severe sepsis are emerging, updated epidemiological information is required. DESIGN AND
SETTING: An inception cohort study conducted in 206 ICUs of randomly selected hospitals over a 2-week period in 2001, including all patients meeting criteria for clinically or microbiologically documented severe sepsis (with > or =1 organ dysfunction). MEASUREMENTS AND
RESULTS: Among 3738 admissions, 546 (14.6%) patients experienced severe sepsis or shock, of which 30% were ICU-acquired. The median age of patients was 65 years, and 54.1% had at least one chronic organ system dysfunction. The median (range) Simplified Acute Physiology Score (SAPS II) and Sequential Organ Failure Assessment (SOFA) at onset of severe sepsis were 48 (2-129) and 9 (1-24), respectively. Mortality was 35% at 30 days; at 2 months the mortality rate was 41.9%, and 11.4% of patients remained hospitalized. The median (range) hospital stay was 25 (0-112) days in survivors and 7 (0-90) days in non-survivors. Chronic liver and heart failure, acute renal failure and shock, SAPS II at onset of severe sepsis and 24-h total SOFA scores were the independent risk factors most strongly associated with death.
CONCLUSIONS: Although the attack rate of severe sepsis in French ICUs appears to have increased over the past decade, its associated mortality has decreased, suggesting improved management of patients. Severe sepsis incurs considerable resources use, and implementation of effective management strategies and continued research efforts are needed.

Entities:  

Mesh:

Year:  2004        PMID: 14997295     DOI: 10.1007/s00134-003-2121-4

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  34 in total

Review 1.  New strategies for clinical trials in patients with sepsis and septic shock.

Authors:  J Cohen; G Guyatt; G R Bernard; T Calandra; D Cook; D Elbourne; J Marshall; A Nunn; S Opal
Journal:  Crit Care Med       Date:  2001-04       Impact factor: 7.598

Review 2.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

3.  Evaluation of definitions for sepsis.

Authors:  W A Knaus; X Sun; O Nystrom; D P Wagner
Journal:  Chest       Date:  1992-06       Impact factor: 9.410

4.  Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; A de Mendonça; F Cantraine; R Moreno; J Takala; P M Suter; C L Sprung; F Colardyn; S Blecher
Journal:  Crit Care Med       Date:  1998-11       Impact factor: 7.598

5.  Bacteremia and severe sepsis in adults: a multicenter prospective survey in ICUs and wards of 24 hospitals. French Bacteremia-Sepsis Study Group.

Authors:  C Brun-Buisson; F Doyon; J Carlet
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

6.  Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis.

Authors:  E Wesley Ely; Pierre-François Laterre; Derek C Angus; Jeffrey D Helterbrand; Howard Levy; Jean-François Dhainaut; Jean-Louis Vincent; William L Macias; Gordon R Bernard
Journal:  Crit Care Med       Date:  2003-01       Impact factor: 7.598

7.  Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients.

Authors:  D Pittet; B Thiévent; R P Wenzel; N Li; R Auckenthaler; P M Suter
Journal:  Am J Respir Crit Care Med       Date:  1996-02       Impact factor: 21.405

8.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

9.  The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock.

Authors:  I Salvo; W de Cian; M Musicco; M Langer; R Piadena; A Wolfler; C Montani; E Magni
Journal:  Intensive Care Med       Date:  1995-11       Impact factor: 17.440

10.  Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis.

Authors:  C Brun-Buisson; F Doyon; J Carlet; P Dellamonica; F Gouin; A Lepoutre; J C Mercier; G Offenstadt; B Régnier
Journal:  JAMA       Date:  1995-09-27       Impact factor: 56.272

View more
  177 in total

1.  Melatonin augments apoptotic adipose-derived mesenchymal stem cell treatment against sepsis-induced acute lung injury.

Authors:  Hong-Hwa Chen; Chia-Lo Chang; Kun-Chen Lin; Pei-Hsun Sung; Han-Tan Chai; Yen-Yi Zhen; Yi-Ching Chen; Ying-Chung Wu; Steve Leu; Tzu-Hsien Tsai; Chih-Hung Chen; Hsueh-Wen Chang; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2014-10-11       Impact factor: 4.060

2.  Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria.

Authors:  Peter M C Klein Klouwenberg; David S Y Ong; Marc J M Bonten; Olaf L Cremer
Journal:  Intensive Care Med       Date:  2012-04-05       Impact factor: 17.440

Review 3.  Urosepsis--Etiology, Diagnosis, and Treatment.

Authors:  Nici Markus Dreger; Stephan Degener; Parviz Ahmad-Nejad; Gabriele Wöbker; Stephan Roth
Journal:  Dtsch Arztebl Int       Date:  2015-12-04       Impact factor: 5.594

4.  Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.

Authors:  Vesna Degoricija; Mirella Sharma; Ante Legac; Marina Gradiser; Sinisa Sefer; Zeljko Vucicević
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

5.  Sepsis syndrome in Croatian intensive care units: piloting a national comparative clinical database.

Authors:  Vladimir Gasparović; Ivan Gornik; Dragutin Ivanović
Journal:  Croat Med J       Date:  2006-06       Impact factor: 1.351

6.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  The significance of non-sustained hypotension in emergency department patients with sepsis.

Authors:  Michael R Marchick; Jeffrey A Kline; Alan E Jones
Journal:  Intensive Care Med       Date:  2009-02-24       Impact factor: 17.440

8.  Immature platelet fraction in predicting sepsis in critically ill patients.

Authors:  Roberto Alberto De Blasi; Patrizia Cardelli; Alessandro Costante; Micol Sandri; Marco Mercieri; Roberto Arcioni
Journal:  Intensive Care Med       Date:  2012-10-24       Impact factor: 17.440

9.  Epidemiology of sepsis: recent advances.

Authors:  Pajman Danai; Greg S Martin
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

10.  [Sepsis : putting knowledge into practice].

Authors:  S N Stehr; I Woest; C S Hartog; K Reinhart
Journal:  Internist (Berl)       Date:  2013-01       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.